Andersen Products.Andersen Products, Haw River, NC, June 28 (Atlanta). Deviations from the QS rule in the manufacture of sterile medical devices, such as nasogastric tubes, sump pumps/tubes, intestinal tubes and wound drainage tubes, included unvalidated equipment for testing Shirley Wound Drain vent filters; incomplete validation of the Packaging Aids Impulse Sealer sealer, n a substance used to fill the space around silver or gutta-percha points in a pulp canal. Most contain some combination of zinc, barium, and bismuth salts and eugenol, Canadian balsam, and eucalyptol. , the laboratory autoclave autoclave Vessel, usually of steel, able to withstand high temperatures and pressures. The chemical industry uses various types of autoclaves in manufacturing dyes and in other chemical reactions requiring high pressures. and the Sterijet sterilization sterilization Any surgical procedure intended to end fertility permanently (see contraception). Such operations remove or interrupt the anatomical pathways through which the cells involved in fertilization travel (see reproductive system). process; uninvestigated complaints regarding possible failure of products to meet specifications; complaint-handling procedures that did not define required evaluation, investigation and actions to be taken; a lack of documentation to show maintenance and humidity sensor calibration for the Herrtronic Herrmidifier; a lack of design changes procedures; and failure to monitor or test deionized water for microbiological and chemical quality. The water was used in the production of microbiological media, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. said. The agency also termed the devices misbranded mis·brand tr.v. mis·brand·ed, mis·brand·ing, mis·brands To brand or label misleadingly or fraudulently. Adj. 1. because the company failed to submit Medical Device Reporting information regarding a nasogastric tube and a Miller-Abbott type intestinal tube. Premarket submissions and export certificates will not be approved until the violations are corrected. FDA considered the firm's proposed corrective actions, submitted in a May 19 response, adequate. The plant was inspected April 19-29. AE, C-H, Design, Val |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion